The role of F-18 fluorodeoxyglucose PET/CT for detecting recurrence in asymptomatic gastric patients after curative resection

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter J.W. Lee
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors J.W. Lee1, S.M. Lee2, M.-. Lee3
  • 1International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Republic of Korea, /
  • 2Soonchunhyang University Hospital, Cheonan, Republic of Korea, /
  • 3Department of Surgery, Soonchunhyang University Hospital, Cheonan, Republic of Korea, /

Abstract

F-18 Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) has been known to be an effective imaging modality in detecting gastric cancer recurrence. However, only a few studies have evaluated the diagnostic performance of FDG PET/CT as a surveillance imaging tool during clinical follow-up in asymptomatic gastric cancer patients after curative resection. This study was aimed to assess the clinical role of surveillance FDG PET/CT for detecting cancer recurrence in asymptomatic gastric cancer patients after curative resection.